The ‘ten commandments’ for the 2025 ESC/EACTS guidelines for the management of valvular heart disease

医学 瓣膜性心脏病 心脏病学 内科学 心力衰竭 梅德林 心脏病 疾病 疾病管理 心脏瓣膜 重症监护医学 血流动力学
作者
Michael Andrew Borger,Fabien Praz
出处
期刊:European Heart Journal [Oxford University Press]
卷期号:47 (22): 2724-2726 被引量:11
标识
DOI:10.1093/eurheartj/ehag096
摘要

Several important advances necessitated an update of the previous version of the European Society of Cardiology/European Association of Cardiothoracic Surgery Guidelines for the management of valvular heart disease (VHD).1 The 2025 VHD Task Force aimed to produce a concise, practical, and patient-centered document (Figure 1) to guide clinicians in an era of rapid advancements. The following list of ‘Ten Commandments’ is a brief summary of the full document,2 which readers are encouraged to consult in more detail. Heart Team and Heart Valve Centres: Multidisciplinary Heart Teams taking care of VHD patients should work within a regional Heart Valve Network.3 Patients with complex conditions and those requiring complex procedures with a clear volume-outcome relationship should be managed in expert Heart Valve Centres with on-site interventional cardiology and cardiac surgery departments to attain optimal outcomes. Patient-centered care and shared decision-making: Patients’ preferences and goals should be acknowledged by the Heart Team in a shared-decision making process. While treatment recommendations are based on medical information synthesized by the Heart Team, the final decision is made together with the informed patient, considering goals and preferences (Figure 1). Advanced cardiac imaging: Echocardiography remains the primary method for screening and VHD grading, but the increasing role of cardiac computed tomography and cardiac magnetic resonance is stressed throughout the guidelines. Accurate determination of valvular lesion severity and etiology, as well as assessment of associated cardiac damage and pre-procedural planning, requires a combination of these techniques. VHD-associated conditions: Recommendations regarding the diagnosis and treatment of associated coronary artery disease have been modified, with an increasing role for coronary computed tomography angiography.4 Recommendations for concomitant surgical atrial fibrillation ablation and closure of the left atrial appendage have been upgraded for patients undergoing surgery. Earlier intervention in the disease process: New left ventricle indexed thresholds have been introduced for recommending surgery in patients with asymptomatic AR and primary mitral regurgitation (MR). Patients with asymptomatic severe high gradient aortic stenosis (AS) and a LVEF ≥50% have a new Class IIa Level of Evidence (LOE) A recommendation for early intervention as an alternative to close surveillance.5 Intervention for TR should be performed prior to the onset of significant RV dysfunction. New transcatheter aortic valve intervention (TAVI) insights: The age for recommending TAVI in patients with tricuspid AS has been lowered to 70 years, irrespective of patient risk. Non-transfemoral TAVI may be applied in patients at high risk for surgery with unsuitable femoral access. TAVI is an alternative for AR and bicuspid AS patients who are ineligible for surgery. New indications for primary MR: Surgery remains the procedure of choice for patients with primary MR. Clinical triggers for recommending surgery in patients with asymptomatic MR have been listed in a new Class I LOE B recommendation.6 Transcatheter edge-to-edge repair (TEER) is an increasingly used alternative for high-risk patients with suitable anatomy. Atrial and ventricular secondary MR: For the first time, diagnostic criteria and distinct treatment pathways have been established for atrial and ventricular secondary MR, two patient groups with markedly different etiologies and prognoses.7 The recommendation for TEER in selected heart failure patients (LVEF < 50%) with associated severe ventricular secondary MR has been upgraded to Class I LOE A based on three randomized controlled trials and one meta-analysis.8 Refinements in TR treatment pathways: Recommendations for TR surgery in patients requiring left-sided valvular surgery have been modified based on the results of a randomized controlled trial with focus on patients with moderate or more TR, while repair may be considered in selected patients with mild TR and annulus dilatation.9 Transcatheter intervention should be considered in high-risk patients with severe symptomatic TR despite appropriate medical therapy to improve quality of life and RV remodeling.10 Clinician-friendly section on anticoagulation in VHD: Several new recommendations have been added for oral anticoagulation (OAC) management after mechanical heart valve implantation, including bridging before and after non-cardiac surgery and the role of patient education. The increasing role of direct oral anticoagulants in patients with a biological valve prosthesis and a preexisting indication for OAC is also highlighted. Clinician-friendly algorithms clearly display recommended antithrombotic management after all types of VHD interventions. Patient-centered evaluation for treatment of valvular heart disease (VHD) from the 2025 European Society of Cardiology/European Association of Cardiothoracic Surgery Guidelines for the management of VHD (Praz et al.2) M.B. discloses that his hospital receives speakers honoraria and/or consulting fees on his behalf from Edwards Lifesciences, Medtronic, Abbott and Artivion. F.P. has been compensated for travel expenses from Edwards Lifesciences, Abbott Vascular, Medira, Siemens Healthineers, and InQB8 Medical Technologies and has received a research grant to the institution from Abbott Vascular.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
陈杰77完成签到,获得积分20
刚刚
在水一方的应助被Suifqh采纳,获得10
刚刚
研友_8Y2DXL完成签到,获得积分10
1秒前
sun完成签到,获得积分10
1秒前
老实人sdu发布了新的文献求助10
1秒前
羲成完成签到,获得积分10
3秒前
慕青的应助被哈哈哈采纳,获得10
3秒前
3秒前
小二郎的应助被moriaty采纳,获得10
5秒前
火星上的海亦完成签到,获得积分10
6秒前
我是老大的应助被洁净的千凡采纳,获得10
6秒前
小木没有烦恼完成签到 ,获得积分10
6秒前
理穆辛完成签到 ,获得积分10
6秒前
7秒前
外向夜春完成签到 ,获得积分10
8秒前
小艾同学发布了新的文献求助10
8秒前
Roux给Roux的求助进行了留言
9秒前
善良的采蓝的应助被土豪的城采纳,获得30
9秒前
hhh发布了新的文献求助10
11秒前
Davin_ji完成签到 ,获得积分10
11秒前
星辰大海的应助被wwwwwl采纳,获得10
12秒前
12秒前
13秒前
13秒前
14秒前
椰子鸡完成签到 ,获得积分10
14秒前
14秒前
14秒前
Charles完成签到,获得积分10
15秒前
15秒前
15秒前
fantasy的应助被隔岸采纳,获得10
15秒前
芽卉完成签到 ,获得积分10
16秒前
爆米花的应助被鼻毛好胜采纳,获得10
16秒前
乐乐的应助被111采纳,获得10
17秒前
WZJ发布了新的文献求助30
17秒前
chaoqi完成签到,获得积分10
18秒前
CipherSage的应助被Leonard采纳,获得10
18秒前
Danny完成签到,获得积分20
18秒前
19秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
八旗制度の研究 600
Boundaries and Bodhisattvas 500
高分子基功能界面水蒸发材料与应用研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8181498
求助须知:如何正确求助?哪些是违规求助? 9571421
关于积分的说明 21817968
捐赠科研通 7777967
什么是DOI,文献DOI怎么找? 3433508
关于科研通互助平台的介绍 2557696
邀请新用户注册赠送积分活动 2479552